NCT03263312View on ClinicalTrials.gov

Multimodality Biomarkers for Noninvasive Assessment of the Fontan Patient

NAUnknownINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Single-ventricleMyocardial Fibrosis

Interventions

BEHAVIORAL

Exercise

Exercise training all patients enrolled.

Trial Locations (1)

75063

Children'sMCD, Irving

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Maria Bano

OTHER

NCT03263312 - Multimodality Biomarkers for Noninvasive Assessment of the Fontan Patient | Biotech Hunter | Biotech Hunter